Focal myositis

disease
On this page

Also known as focal nodular myositisinflammatory pseudotumor of skeletal muscle

Summary

Focal myositis (MONDO:0018845) is a disease. A subtype of acquired idiopathic inflammatory myopathy — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
  • Phenotypes (HPO): 7

Clinical features

Epidemiology

Prevalence records

2 prevalence record(s), Orphanet:

TypeClassValueGeographyValidation
Cases/families115WorldwideValidated
Point prevalence<1 / 1 000 000WorldwideValidated

Signs & symptoms

Clinical features (HPO)

7 HPO clinical features (Orphanet curated; top 7 by frequency):

HPO IDTermFrequency
HP:0100614MyositisVery frequent (80-99%)
HP:0003236Elevated circulating creatine kinase concentrationFrequent (30-79%)
HP:0001324Muscle weaknessOccasional (5-29%)
HP:0001376Limitation of joint mobilityOccasional (5-29%)
HP:0001824Weight lossOccasional (5-29%)
HP:0001945FeverOccasional (5-29%)
HP:0003326MyalgiaOccasional (5-29%)

Identifiers

Disease identifiers

FieldValue
Canonical namefocal myositis
Mondo IDMONDO:0018845
Orphanet48918
ICD-11708931518
SNOMED CT240119009
UMLSC0409988
MedGen592748
GARD0018837
Is cancer (heuristic)no

Also known as: focal nodular myositis · inflammatory pseudotumor of skeletal muscle

Disease family

This is a subtype of acquired idiopathic inflammatory myopathy. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › musculoskeletal system disordermuscle tissue disorderskeletal muscle disorder › acquired skeletal muscle disease › acquired idiopathic inflammatory myopathyfocal myositis

Related subtypes (8): eosinophilic fasciitis, immune-mediated necrotizing myopathy, overlap myositis, inflammatory myopathy with abundant macrophages, idiopathic eosinophilic myositis, juvenile idiopathic inflammatory myopathy, polymyositis, antisynthetase syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.